BNT211: A Phase I trial to evaluate safety and efficacy of CLDN6 CAR-T cells and CARVac-mediated in vivo expansion in patients with CLDN6-positive advanced solid tumorsJohn B. A. G. Haanen,Andreas Mackensen,Christian Koenecke,Winfried Alsdorf,Eva Wagner-Drouet,Daniel Heudobler,Peter Borchmann,Carsten Bokemeyer,Sebastian Klobuch,Alexander Desuki,Florian Lueke,Erol Wiegert,Catrine Schulz,Benjamin Rengstl,Liane Preussner, Oezlem Tuereci,Ugur SahinHUMAN GENE THERAPY（2022）引用 0|浏览5暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
